O'Dell Group’s CorMedix CRMD Stock Holding History

O'Dell Group’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-705	Closed	-$4K	–	479
2022 Q1	$4K	Hold	705	–	–	﹤0.01%	404
2021 Q4	$3K	Hold	705	–	–	﹤0.01%	425
2021 Q3	$3K	Buy	+705	New	+$4.11K	﹤0.01%	412

Other funds holding CRMD

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

O'Dell Group's CRMD Position: Q2 2022 in Review

O'Dell Group sold out of CorMedix (CRMD) in Q2 2022, closing a stake of 705 shares — an estimated $4K sold.

O'Dell Group first reported a position in CRMD in Q3 2021 and held it in 3 quarters. The position peaked at $4K in Q1 2022. 74 funds tracked by Wall St. Rank hold CRMD as of Q2 2022.

O'Dell Group reported no remaining CorMedix position as of Q2 2022 after selling out during the quarter.
O'Dell Group sold 705 CorMedix shares in Q2 2022, an estimated $4K.
O'Dell Group first reported a position in CorMedix in Q3 2021 and held it in 3 quarters.
O'Dell Group's CorMedix position peaked at $4K in Q1 2022.
74 funds tracked by Wall St. Rank held CorMedix as of Q2 2022.

Based on O'Dell Group's 13F filing for Q2 2022, filed 11 Aug 2022.